Literature DB >> 19885717

Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics.

Henning Budde1, Thomas Sander, Catrin Wernicke, Anett Müller, Jürgen Gallinat, Lutz G Schmidt, Michael N Smolka.   

Abstract

The central serotonin (5-HT) system plays an important role in the rewarding and addictive properties of alcohol by a direct activation of the mesolimbic dopamine (DA) system. An insertion/deletion (L/S) promoter polymorphism (5-HTTLPR) of the 5-HT transporter (5-HHT) gene (SLC6A4) has been shown to influence transcriptional activity. It is predicted that reduced transynaptic 5-HT neurotransmission in alcoholics with the L/L genotype of 5-HTTLPR would result in a change in DA function compared to the S/S genotype. Thus the present study has tested whether dopaminergic sensitivity is influenced by the 5-HTTLPR genotype. Dopaminergic sensitivity, 5-HTTLPR genotype and smoking status were assessed in 121 alcoholics. Dopaminergic sensitivity as an indicator of the functional state of the dopaminergic system was measured by the amount of growth hormone (GH) secretion after subcutaneous administration of apomorphine (APO, 0.01 mg/kg). 5-HTTLPR genotype was significantly associated with dopaminergic sensitivity (P = 0.004) explaining 9.2% of the variance of GH response. Subjects homozygous for the L allele (with high 5-HTT expression) showed the lowest GH response, whereas those homozygous for the S allele (with low 5-HTT expression) showed the highest GH response (this was intermediate in heterozygous participants). Furthermore smoking was associated with a significantly reduced GH response (P = 0.006). Our findings indicate that the postsynaptic dopaminergic sensitivity is influenced by the 5-HTTLPR genotype. It is hypothesized that the reduction of sensitivity of the central DA receptors in alcoholics with the L/L genotype might be due to their higher vulnerability to the neurotoxic effects of chronic alcohol consumption than the S carriers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885717     DOI: 10.1007/s00702-009-0331-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  30 in total

1.  Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

Authors:  Martin A Javors; Chamindi Seneviratne; John D Roache; Nassima Ait-Daoud; Susan E Bergeson; M Consuelo Walss-Bass; Fatema Z Akhtar; Bankole A Johnson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-04       Impact factor: 5.067

2.  Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.

Authors:  Henning Budde; Ulrich S Zimmermann; Birgit Steffin; Hans Rommelspacher; Lutz G Schmidt; Michael N Smolka
Journal:  Alcohol Clin Exp Res       Date:  2007-01       Impact factor: 3.455

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

Authors:  A Heinz; D W Jones; C Mazzanti; D Goldman; P Ragan; D Hommer; M Linnoila; D R Weinberger
Journal:  Biol Psychiatry       Date:  2000-04-01       Impact factor: 13.382

Review 5.  Genotype effects on neurodegeneration and neuroadaptation in monoaminergic neurotransmitter systems.

Authors:  A Heinz; D Goldman
Journal:  Neurochem Int       Date:  2000 Nov-Dec       Impact factor: 3.921

Review 6.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

7.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

Review 8.  Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine.

Authors:  O Blomqvist; M Ericson; J A Engel; B Söderpalm
Journal:  Eur J Pharmacol       Date:  1997-09-10       Impact factor: 4.432

10.  Allelic variation of human serotonin transporter gene expression.

Authors:  A Heils; A Teufel; S Petri; G Stöber; P Riederer; D Bengel; K P Lesch
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372

View more
  3 in total

Review 1.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

2.  Differential impact of serotonin transporter activity on temperament and behavior in persons with a family history of alcoholism in the Oklahoma Family Health Patterns Project.

Authors:  William R Lovallo; Mary-Anne Enoch; Eldad Yechiam; David C Glahn; Ashley Acheson; Kristen H Sorocco; Colin A Hodgkinson; Bojeong Kim; Andrew J Cohoon; Andrea S Vincent; David Goldman
Journal:  Alcohol Clin Exp Res       Date:  2014-05-05       Impact factor: 3.455

3.  Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder.

Authors:  Jian Cao; James J Hudziak; Dawei Li
Journal:  Neuropsychopharmacology       Date:  2013-03-21       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.